NOVADOZ PHARMACEUTICALS LLC recalls Glycopyrrolate Oral Solution
- Recalling company
- NOVADOZ PHARMACEUTICALS LLC
- Product
- Glycopyrrolate Oral Solution, 1 mg/5 mL, 16 oz. (473 mL), Rx only, Manufactured by: MSN Pharmaceuticals Inc., Piscataway, NJ 08854, Distributed by: Novadoz Pharmaceuticals LLC, Piscataway, NJ 08854, NDC 72205-070-72
- Reason
- Failed Impurities/Degradation Specifications
- Classification
- Class III – not likely to cause adverse health consequences
- Recall date
- Dec 15, 2025
- Reported
- Feb 4, 2026
- Distribution
- US Nationwide.
- Status
- Ongoing
- Quantity
- N/A
- Lot / codes
- Lot # CB2505159A, CB2505160A, Exp Date: 04/2027; Lot # CB2505161A, Exp Date: 05/2027
- Company location
- Piscataway, NJ
- Recall type
- Voluntary: Firm initiated
- Recall number
- D-0300-2026
- Agency
- U.S. Food and Drug Administration (FDA)
View official FDA notice ↗ Search recall number D-0300-2026 in the FDA Enforcement Report. Also see FDA recall press releases.
If you use this product, check the lot, NDC or model number against the official notice and follow its instructions. Do not stop a prescribed medicine or remove a medical device without talking to your doctor or pharmacist. Report problems to FDA MedWatch. FoodRecallNow summarizes public FDA data and is not medical advice.